Floatz logo

Enalapril Maleate

Isolated Systolic Hypertension

Shenzhen Ausa Pharmed Co.,LtdPhase 4 / ApprovedDormant
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Isolated Systolic Hypertension cohort.

Asset / SponsorPhaseRating
nitrendipine
KU Leuven
Phase 2CCC

Same molecule, other indications

Enalapril Maleate is also rated in:

hyperhomocysteinemiaDormant
BB
Indicative ·
69 / 100
View asset →
essential hypertensionDormant
BB
Indicative ·
67 / 100
View asset →
hypertensive disorderDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →